
Keywords: VH, variable heavy chain domain; VL, variable light chain domain; mAb, monoclonal antibody; bsAb, bispecific antibody; scFv, single chain variable fragment; Triomab, trifunctional hybrid antibody; TaFv, tandem single chain variable fragment; BiTE, bispeci